As of Apr 24
| +0.04 / +1.86%|
The 3 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +219.63% increase from the last price of 2.19.
The current consensus among 3 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.